TBA · NSE,BSE · industrial manufacturing
Pioneer Fil-Med IPO is scheduled to open soon . The Mainboard IPO has a price band of TBA , with a minimum lot size of TBA . .
Pioneer Fil-Med IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | TBA |
| IPO Close Date | TBA |
| Basis of Allotment | TBA |
| Initiation of Refunds | TBA |
| Credit of Shares to Demat | TBA |
| Listing Date | TBA |
Issue Size
₹500.00 Cr
Issue Price
[.]
Face Value
₹10/share
Market Lot
[.]
Retail Min Investment
[.]
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
₹250 Cr
Offer for Sale
₹250 Cr
Issue Type
book building
Open Date
TBA
Close Date
TBA
Allotment
TBA
Listing
TBA
No snapshot available yet.
Pioneer Facor IT Infradevelopers Private Limited, Pioneer Procon Private Limited, Pioneer Securities Private Limited and Pioneer Fincap Private Limited are the company promoters.
Pioneer Fil-Med Limited is an established Indian manufacturer of railway and metro equipment (traction motors, alternators, brake discs, gangways, platform screen doors) and wind generator components. It supplies mainly to Indian Railways, metro corporations and wind turbine makers and is among the top three Category-I approved suppliers for traction alternators and a Category-I supplier for traction motors and HHP 4500 motors.
Strengths
Growth The company is expanding capacity by setting up a new gear-box and wind-generator-components manufacturing facility at Salarpur, Bhiwadi, Rajasthan (expected operational by Sep 2026). It is also diversifying into platform screen doors for metros and growing its wind-energy business. Industry tailwinds are strong: Indian rolling-stock market is projected to grow at 25.3% CAGR (FY25–30) and wind-turbine components at 17.8% CAGR, supported by railway electrification, metro expansion and 100 GW wind target. Revenue has grown from ₹86 Cr in FY23 to ₹326 Cr in FY25 with PAT margin improving to 12.39%. The IPO proceeds will part-finance the new facility and general corporate purposes, supporting further scale-up.
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Total Revenue | 90.38 | 235.61 | 331.13 |
| Profit After Tax (PAT) | 11.17 | 26.39 | 40.44 |
| EBITDA | 33.61 | 57.51 | 39.55 |
| Total Assets | 151.88 | 181.19 | 225.49 |
| Net Worth | 77.36 | 100.29 | 137.28 |
| Reserves & Surplus | - | - | - |
| Total Borrowing | 21.8 | 8.51 | 18.55 |
Revenue & Profit Trend
The allotment date for Pioneer Fil-Med IPO will be announced after the subscription closes. You can check your allotment status using your PAN number or application number on the MUFG Intime India Pvt.Ltd portal or BSE.
The Pioneer Fil-Med IPO dates are coming soon. The subscription dates will be announced officially by the company and updated here once finalized.
The price band for Pioneer Fil-Med IPO is yet to be announced.
As per market sources, Pioneer Fil-Med IPO GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Pioneer Fil-Med IPO is being updated. Check the latest subscription figures by category (Retail, QIB, NII) for real-time updates.
The listing date for Pioneer Fil-Med IPO is yet to be announced and will be updated once finalized.
No comments yet. Be the first to comment!